Pain arising when inflammatory mediators (prostaglandins, bradykinin, TNF-Ξ±, IL-1beta) sensitize nociceptors and recruit non-nociceptive neurons, creating both peripheral sensitisation and central sensitization. Unlike Nociceptive pain (which requires ongoing tissue damage), inflammatory pain persists as long as inflammatory signaling continues, independent of actual tissue injury. It represents a transitional state between protective acute pain and pathological chronic pain.
The Overzealous Fire Alarm System
Imagine a building with a normal fire alarm system (nociceptive pain) β it rings when there's actual fire (tissue damage). Now suppose someone sprays irritant chemicals throughout the building (inflammatory mediators). The alarm sensors become hypersensitive β now even candle smoke triggers them. Worse, motion detectors (non-pain sensors) that normally ignore movement start activating the alarm too. The central control panel (spinal cord) gets so many false signals it starts amplifying everything β a cigarette lighter looks like an inferno.
Even after the chemical spray dissipates from the rooms (tissue heals), residue remains on the sensors and wiring (sensitized pathways). The building stays on high alert for weeks. Someone walking past with a match (normally harmless stimulus) triggers full evacuation sirens (allodynia). The system has learned to overreact β it's protecting against a threat that no longer exists. This is inflammatory pain: the alarm infrastructure itself has been chemically modified to create persistent, amplified signals independent of actual danger.
Inflammatory pain involves a molecular cascade that transforms the pain system at multiple levels:
Peripheral Sensitization (at the tissue level):
-
Inflammatory Mediator Release:
-
Nociceptor Sensitization:
- PGE2 β EP receptors β PKA activation β phosphorylation of TRPV1 and voltage-gated sodium channels (Nav1.7, Nav1.8)
- Bradykinin β B2 receptors β PKC activation β further TRPV1 sensitization
- TNF-Ξ± β TNFR1 β p38 MAPK pathway β enhanced sodium channel expression
- Result: Nociceptors fire at LOWER thresholds (hyperalgesia) and show INCREASED response magnitude
-
Ion Channel Modulation:
- TRPV1 activation threshold drops from 43Β°C to 35Β°C (now body temperature activates it)
- TRPA1 becomes responsive to non-noxious mechanical stimuli
- Voltage-gated sodium channels accumulate in nociceptor terminals, increasing excitability
Neurogenic Inflammation (peripheral amplification loop):
- Neuropeptide Release:
- Activated nociceptors release substance P and CGRP from their peripheral terminals (antidromic conduction)
- Substance P β NK1 receptors on blood vessels β vasodilation, plasma extravasation
- CGRP β CGRP receptors β further vasodilation
- Both neuropeptides β mast cell degranulation β more inflammatory mediator release
- Creates positive feedback loop: pain β inflammation β more pain
Central Sensitization (spinal cord changes):
-
Dorsal Horn Plasticity:
- Primary afferents release substance P and glutamate at dorsal horn synapses
- Substance P β NK1 receptors on second-order neurons β prolonged depolarization
- Glutamate β NMDA receptors (normally blocked by MgΒ²βΊ) β with sustained depolarization, MgΒ²βΊ block removed
- NMDA activation β CaΒ²βΊ influx β PKC, CaMKII activation
- Result: Long-term potentiation (LTP) of pain pathways
-
Phenotypic Switching:
- A-beta fibres (normally touch/pressure) begin expressing substance P
- These low-threshold mechanoreceptors now activate pain pathways
- Mechanism: NGF β TrkA receptors β changes in gene expression
- Clinical manifestation: allodynia (light touch becomes painful)
-
Descending Modulation Changes:
graph TD
A[Tissue Injury/Inflammation] --> B["COX-2 β PGE2"]
A --> C["Immune cells β TNF-Ξ±, IL-1Ξ²"]
A --> D["Mast cells β Histamine"]
B --> E[EP Receptors on Nociceptors]
C --> F[TNFR1 on Nociceptors]
D --> G[H1 Receptors]
E --> H[PKA Activation]
F --> I[p38 MAPK]
H --> J[TRPV1 Phosphorylation]
H --> K["Nav Channel Expression β"]
I --> K
J --> L[Lower Activation Threshold]
K --> L
L --> M[Nociceptor Hyperexcitability]
M --> N["Substance P + CGRP Release"]
N --> O["Peripheral Terminals: Neurogenic Inflammation"]
N --> P[Spinal Dorsal Horn]
O --> Q["Vasodilation + Mast Cell Degranulation"]
Q --> C
P --> R["Glutamate + Substance P on 2nd Order Neurons"]
R --> S[NMDA Receptor Activation]
S --> T["CaΒ²βΊ Influx β PKC"]
T --> U[Central Sensitization LTP]
P --> V["NGF β AΞ² Fiber Phenotype Switch"]
V --> W["Allodynia: Touch = Pain"]
U --> X[Chronic Pain State]
W --> X
Resolution Failure:
- When Resolution Mechanisms Fail:
- Normally specialized pro-resolving mediators (resolvins, maresins, protectins) terminate inflammation
- In chronic inflammatory pain: inadequate SPMs production or receptor desensitization
- Persistent inflammation maintains sensitized state even after tissue healing complete
Patient Populations:
Inflammatory pain is the dominant mechanism in:
- Post-operative patients β explains why pain persists 3-7 days after surgery despite wound closure within 48 hours; inflammatory cascade outlasts tissue damage
- Rheumatoid arthritis β synovial inflammation creates persistent joint pain with morning stiffness (inflammatory mediators accumulate overnight)
- Inflammatory bowel disease (Crohn's, ulcerative colitis) β visceral inflammatory pain with Visceral Hypersensitivity
- Chronic low back pain β once facet joint or disc inflammation begins, can transition from nociceptive to inflammatory mechanism
- Fibromyalgia β may involve central sensitization initially triggered by inflammatory events
Connection to cPNI Frameworks:
- Selfish Immune System perspective: The immune system prioritizes pathogen defense over pain reduction β inflammatory mediators are dual-purpose signals (antimicrobial + nociceptive), so pain is tolerated as "acceptable collateral damage"
- Mismatch paradigm: Modern sedentary lifestyle reduces natural anti-inflammatory mechanisms (muscle-derived IL-10, exercise-induced SPM production), while processed food increases pro-inflammatory state β creates environment where inflammatory pain persists
- Allostatic load: Chronic inflammatory pain represents failed resolution β the system remains stuck in defensive mode, unable to return to homeostasis
Clinical Thresholds:
- IL-6 levels >10 pg/mL correlate with pain intensity in RA patients
- CRP >3 mg/L suggests ongoing systemic inflammation maintaining pain
- Allodynia threshold: mechanical detection threshold <0.4g (von Frey filament testing) indicates AΞ² fiber recruitment
- Temporal summation (wind-up pain): >20% increase in pain with repeated stimuli indicates central sensitization
Intervention Implications:
-
Peripheral Targets:
- NSAIDs effective early (block COX-2 β reduce PGE2) β timing matters, most effective within first 48 hours
- Specialized pro-resolving mediators (omega-3 derived resolvins) actively terminate inflammation rather than just blocking it
- Curcumin, Boswellia β inhibit multiple inflammatory pathways (NF-ΞΊB, 5-LOX)
-
Central Targets:
- Gabapentinoids (pregabalin) β block voltage-gated calcium channels, reduce glutamate release
- Low-dose Naltrexone β modulates microglial activation, reduces central sensitization
- Pain neuroscience education β reduces fear-avoidance, modulates descending inhibition
-
Resolution-Promoting:
- High-dose EPA/DHA (2-4g daily) β substrate for SPM synthesis
- Exercise β triggers IL-10 release from muscle, promotes SPM production
- Sleep optimization β SPM synthesis peaks during sleep; sleep deprivation impairs resolution
-
Why COX-2 Selective Inhibitors Can Backfire:
- COX-2 is needed for SPM synthesis (aspirin-triggered resolvins require COX-2 acetylation)
- Long-term selective COX-2 inhibition may impair resolution, creating rebound inflammation upon discontinuation
- Inflammatory pain involves BOTH nociceptors AND non-nociceptors (AΞ² fibers), unlike pure nociceptive pain which only involves C and AΞ΄ fibers
- PGE2 lowers TRPV1 activation threshold from 43Β°C to 35Β°C β explains why inflamed tissue is painful even at normal body temperature
- Substance P increases vascular permeability 1000-fold more potently than histamine
- Central sensitization can develop within 60-90 minutes of sustained nociceptive input
- NGF (nerve growth factor) drives phenotypic switching of AΞ² fibers β blocking NGF with tanezumab reduces osteoarthritis pain but FDA concerns about joint destruction
- NMDA receptor activation requires BOTH glutamate binding AND membrane depolarization (removes MgΒ²βΊ block) β explains why central sensitization needs sustained input
- Allodynia affects ~60% of patients with inflammatory conditions; presence indicates transition to central mechanism
- Post-surgical inflammatory pain peaks 24-72 hours (inflammatory cascade timeline), not immediately post-injury
- Omega-3 index <8% associated with prolonged inflammatory pain; >8% correlates with faster resolution
- Bradykinin is 10x more potent than substance P at causing pain, but has shorter half-life (seconds vs minutes)